EXHIBIT 99        CAUTIONARY STATEMENT UNDER PRIVATE SECURITIES
                  LITIGATION REFORM ACT OF 1995 - "SAFE HARBOR" FOR
                  FORWARD-LOOKING DISCLOSURES

Certain  forward-looking  statements  are  included in this Form 10-Q and may be
made by Company  spokespersons based on current expectations of management.  All
forward-looking  statements  made  by the  Company  are  subject  to  risks  and
uncertainties. Certain factors, including but not limited to those listed below,
may cause actual  results to differ  materially  from current  expectations  and
historical results.

- -    Economic factors over which the Company has no control, including changes
     in inflation, interest rates and foreign currency exchange rates.

- -    Competitive factors including generic competition as patents on key
     products, such as Prozac, expire; pricing pressures, both in the U.S. and
     abroad, primarily from managed care groups and government agencies; and
     technological advances and patents obtained by competitors.

- -    Governmental factors including laws and regulations and judicial decisions
     at the state and federal level related to Medicare, Medicaid and healthcare
     reform; and laws and regulations affecting international pricing and
     pharmaceutical reimbursement.

- -    The difficulties and uncertainties inherent in new product development. New
     product candidates that appear promising in development may fail to reach
     the market or may not be as commercially successful as anticipated because
     of efficacy or safety concerns, inability to obtain necessary regulatory
     approvals, limitations on approved indications, difficulty or excessive
     costs to manufacture, or infringement of the patents or intellectual
     property rights of others.

- -    Delays and uncertainties in the FDA approval process and the approval
     processes in other countries, resulting in lost market opportunity.

- -    Unexpected safety or efficacy concerns arising with respect to marketed
     products, whether or not scientifically justified, leading to product
     recalls, withdrawals or declining sales.

- -    Legal factors including unanticipated litigation of product liability
     claims; antitrust litigation; environmental matters; and patent disputes
     with competitors which could preclude commercialization of products or
     negatively affect the profitability of existing products.

- -    Future difficulties obtaining or the inability to obtain existing levels of
     product liability insurance.

- -    Changes in tax laws, including the amendment to the Section 936 income tax
     credit, and future changes in tax laws related to the remittance of foreign
     earnings or investments in foreign countries with favorable tax rates.

- -    Changes in accounting standards promulgated by the Financial Accounting
     Standards Board, the Securities and Exchange Commission, and the American
     Institute of Certified Public Accountants which are adverse to the Company.











- -    Factors such as changes in business strategies and the impact of
     restructurings, impairments in asset carrying values and business
     combinations.

- -    Difficulties in modification or replacement of existing computer systems
     and/or software in order to render the Company's various computer systems
     ready for the year 2000, including the difficulties encountered by third
     party vendors and/or suppliers in their failure to render their systems
     and/or software to be ready for the year 2000.